Ovid Therapeutics Inc. (NASDAQ: OVID) reported fourth-quarter financial results that exceeded analyst expectations, marking a significant shift to profitability. The biotechnology company...
REDWOOD CITY, Calif. — March 9, 2026: Biotechnology firm Coherus BioSciences, Inc. (NASDAQ: CHRS) reported a wider-than-expected fourth-quarter loss after markets closed...
In a significant move for the deep tech investment environment, Breakout Ventures has closed a $114 million Fund III dedicated exclusively to...
March 11, 2026 — ANN ARBOR, Mich. — Shares of Esperion Therapeutics (NASDAQ: ESPR) plummeted approximately 11% in Tuesday’s trading session following...
NEW YORK, March 11, 2026 — A significant capital rotation is underway in the biotechnology sector. Fresh data from ETF Channel reveals...
PLAINSBORO, New Jersey & SAN FRANCISCO, California — March 11, 2026: In a strategic pivot that stunned market observers, Danish pharmaceutical giant...
ROCKVILLE, Md. — March 11, 2026: Shares of clinical-stage biopharmaceutical company MacroGenics, Inc. (NASDAQ: MGNX) crossed a significant threshold in early trading...
San Diego, CA — March 11, 2026: Shares of genomics giant Illumina (NASDAQ: ILMN) have surged a remarkable 44.8% over the past...
BOSTON, March 10, 2026 — Shares of Vertex Pharmaceuticals (VRTX) surged nearly 5% in after-hours trading today following the release of unexpectedly...
FRANKFURT, Germany — March 10, 2026: Shares of biotechnology firm BioNTech SE (BNTX) entered technically oversold territory during Tuesday’s trading session, a...